We are live on ! Find out more
CDH

Charles D. Hyman Portfolio holdings

AUM $1.79B
1-Year Est. Return 17.18%
This Fund
S&P 500
This Quarter Est. Return
+4.37%
1 Year Est. Return
+17.18%
3 Year Est. Return
+36.79%
5 Year Est. Return
+95.96%
10 Year Est. Return
+199.04%
AUM
$594M
AUM Growth
+$40.1M
Cap. Flow
+$17.2M
Cap. Flow %
2.89%
Top 10 Hldgs %
29.79%
Holding
153
New
6
Increased
47
Reduced
44
Closed
2

Top Buys

Rank Stock Value
1
RTX icon
RTX Corp
RTX
+$1.89M
2
F icon
Ford
F
+$1.83M
3
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$1.29M
4
COP icon
ConocoPhillips
COP
+$1.22M
5
CVX icon
Chevron
CVX
+$793K

Sector Composition

Rank Sector Weight
1 Industrials 19.3%
2 Healthcare 11.32%
3 Energy 10.78%
4 Consumer Staples 9.61%
5 Financials 7.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SJM icon
126
J.M. Smucker
SJM
$12.6B
$242K 0.04%
2,272
EOG icon
127
EOG Resources
EOG
$78B
$234K 0.04%
+2,000
New +$210K
PRA
128
DELISTED
ProAssurance
PRA
$234K 0.04%
5,268
QCOM icon
129
Qualcomm
QCOM
$176B
$229K 0.04%
2,890
+101
+4% +$8.03K
AFL icon
130
Aflac
AFL
$63.9B
$223K 0.04%
7,160
LOW icon
131
Lowe's Companies
LOW
$116B
$221K 0.04%
4,600
ED icon
132
Consolidated Edison
ED
$41.6B
$214K 0.04%
+3,714
New +$207K
K
133
DELISTED
Kellanova
K
$214K 0.04%
3,461
PCL
134
DELISTED
PLUM CREEK TIMBER CO (REIT)
PCL
$207K 0.03%
+4,592
New +$200K
OPK icon
135
Opko Health
OPK
$921M
$147K 0.02%
16,619
SONN
136
DELISTED
Sonnet BioTherapeutics
SONN
0
GNMX
137
DELISTED
Aevi Genomic Medicine Inc
GNMX
$113K 0.02%
14,500
RF icon
138
Regions Financial
RF
$26.3B
$107K 0.02%
10,090
-206
-2% -$2.15K
HOTRW
139
DELISTED
CHANTICLEER HLDGS INC WTS EXP 6/11/2017 (DE)
HOTRW
$100K 0.02%
44,444
GOOG icon
140
Alphabet (Google) Class C
GOOG
$3.9T
-9,877
Closed -$274K
LHX icon
141
L3Harris
LHX
$55.9B
-2,963
Closed -$217K
GSX
142
DELISTED
GASCO ENERGY INC
GSX
$0 ﹤0.01%
10,000
CNB
143
DELISTED
COLONIAL BANCGROUP INC
CNB
$0 ﹤0.01%
27,979

Similar funds

Charles D. Hyman's Q2 2014 Portfolio in Review

As of Q2 2014, Charles D. Hyman held 153 positions worth $594M, up 7.2% from $553M the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Charles D. Hyman's Q2 2014 filing shows 6 new, 47 increased, 44 reduced and 2 closed positions. Its largest new stake was iShares MSCI EAFE Growth ETF: 10,920 shares worth $747K. The largest sale was Weyerhaeuser, an estimated $384K.

By sector, the portfolio is most concentrated in Industrials at 19% of assets, down from 19% a quarter earlier, followed by Healthcare and Energy.

  • Charles D. Hyman's largest Q2 2014 buy was iShares MSCI EAFE Growth ETF: 10,920 shares worth $747K.
  • Charles D. Hyman added most to RTX Corp in Q2 2014, an estimated $1.89M increase.
  • Charles D. Hyman's biggest Q2 2014 reduction was Weyerhaeuser, cutting an estimated $384K.
  • Charles D. Hyman fully exited Alphabet (Google) Class C in Q2 2014, selling an estimated $274K.
  • Charles D. Hyman's ten largest holdings make up 30% of its $594M portfolio in Q2 2014.
  • Charles D. Hyman opened 6 new positions and closed 2 in Q2 2014.
  • Charles D. Hyman's portfolio value rose 7.2% quarter-over-quarter to $594M.

Based on Charles D. Hyman's 13F filing for Q2 2014, filed 29 Jul 2014.